Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.79%927.44M | -13.46%796.51M | -2.10%896.47M | -0.10%3.72B | 2.88%948.96M | 13.55%934.8M | -2.02%920.36M | -11.82%915.71M | -13.63%3.72B | -6.46%922.42M |
| Operating revenue | -0.79%927.44M | -13.46%796.51M | -2.10%896.47M | -0.10%3.72B | 2.88%948.96M | 13.55%934.8M | -2.02%920.36M | -11.82%915.71M | -13.63%3.72B | -6.46%922.42M |
| Cost of revenue | -5.82%748.1M | -21.99%580.87M | -21.14%580.65M | -1.91%3.01B | -4.95%734.23M | 8.80%794.3M | 2.78%744.56M | -12.46%736.32M | -10.97%3.07B | -8.13%772.47M |
| Gross profit | 27.64%179.34M | 22.66%215.64M | 76.06%315.83M | 8.39%710.42M | 43.20%214.73M | 50.72%140.51M | -18.23%175.79M | -9.05%179.39M | -24.24%655.4M | 3.21%149.95M |
| Operating expense | 11.68%110.87M | 1.57%102.23M | 11.44%106.1M | -1.56%385.7M | -9.54%90.57M | 1.01%99.28M | 5.44%100.65M | -2.82%95.21M | 5.21%391.83M | 15.92%100.12M |
| Depreciation amortization depletion | 11.68%110.87M | 1.57%102.23M | 11.44%106.1M | -1.56%385.7M | -9.54%90.57M | 1.01%99.28M | 5.44%100.65M | -2.82%95.21M | 5.21%391.83M | 15.92%100.12M |
| -Depreciation and amortization | 11.68%110.87M | 1.57%102.23M | 11.44%106.1M | -1.56%385.7M | -9.54%90.57M | 1.01%99.28M | 5.44%100.65M | -2.82%95.21M | 5.21%391.83M | 15.92%100.12M |
| Operating profit | 66.06%68.47M | 50.92%113.4M | 149.14%209.72M | 23.20%324.72M | 149.15%124.17M | 914.82%41.23M | -37.13%75.14M | -15.21%84.18M | -46.50%263.57M | -15.42%49.84M |
| Net non-operating interest income (expenses) | -499.85%-57.62M | -74.83%-42.73M | -92.46%-46.64M | -55.26%-120.21M | -355.23%-85.95M | 159.47%14.41M | -70.96%-24.44M | -21.04%-24.23M | 26.54%-77.43M | -38.93%-18.88M |
| Non-operating interest income | -92.29%3.26M | 161.69%8.48M | 17.91%4.06M | -68.90%12.42M | -425.77%-36.5M | 1,883.80%42.24M | -79.67%3.24M | -67.68%3.45M | 57.56%39.94M | -37.67%11.21M |
| Non-operating interest expense | 118.80%60.88M | 85.00%51.22M | 83.18%50.7M | 13.01%132.63M | 64.36%49.45M | 5.55%27.82M | -8.46%27.68M | -9.79%27.68M | -10.24%117.37M | -4.69%30.09M |
| Other net income (expenses) | -114.45%-2.86M | -14.38%15.24M | -62.42%4.56M | -24.01%75.58M | 82.29%25.85M | -64.26%19.79M | 275.59%17.8M | -51.76%12.14M | -48.96%99.47M | -29.89%14.18M |
| Special income (charges) | --0 | --19.54M | --8.16M | ---65.72M | --0 | ---65.72M | --0 | --0 | --0 | --0 |
| -Less:Impairment of capital assets | --0 | ---- | ---- | --124.79M | --0 | --124.79M | ---- | ---- | --0 | --0 |
| -Less:Other special charges | ---- | ---19.54M | ---8.16M | ---59.07M | --0 | ---59.07M | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -84.00%11.42M | --19.54M | --8.16M | --102.97M | --31.57M | --71.4M | ---- | ---- | ---- | ---- |
| Income before tax | -89.41%7.99M | 25.42%85.91M | 132.56%167.65M | -1.93%280.09M | 41.94%64.06M | 189.16%75.44M | -37.71%68.5M | -30.97%72.09M | -50.94%285.61M | -31.16%45.13M |
| Income tax | -63.97%3.79M | -44.47%2.68M | 530.26%36.06M | 1,904.10%29.84M | 160.66%8.76M | 160.07%10.53M | -74.74%4.83M | -60.08%5.72M | -98.76%1.49M | -300.71%-14.44M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -93.54%4.19M | 30.72%83.23M | 98.28%131.59M | -11.92%250.25M | -7.16%55.31M | 48.79%64.9M | -29.91%63.67M | -26.34%66.37M | -38.54%284.12M | 2.06%59.57M |
| Net income continuous operations | -93.54%4.19M | 30.72%83.23M | 98.28%131.59M | -11.92%250.25M | -7.16%55.31M | 48.79%64.9M | -29.91%63.67M | -26.34%66.37M | -38.54%284.12M | 2.06%59.57M |
| Noncontrolling interests | -66.71%11.26M | -33.86%18.81M | 47.66%20.31M | -21.57%86.26M | -60.77%10.23M | 74.10%33.83M | -16.69%28.45M | -54.65%13.75M | 1.41%109.98M | 50.45%26.08M |
| Net income attributable to the company | -122.76%-7.07M | 82.89%64.41M | 111.51%111.29M | -5.83%163.99M | 34.59%45.07M | 28.46%31.07M | -37.87%35.22M | -11.97%52.62M | -50.78%174.14M | -18.38%33.49M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -122.76%-7.07M | 82.89%64.41M | 111.51%111.29M | -5.83%163.99M | 34.59%45.07M | 28.46%31.07M | -37.87%35.22M | -11.97%52.62M | -50.78%174.14M | -18.38%33.49M |
| Diluted earnings per share | -119.57%-0.09 | 82.69%0.95 | 111.54%1.65 | -5.45%2.43 | 34.00%0.67 | 27.78%0.46 | -38.10%0.52 | -10.34%0.78 | -48.08%2.57 | -15.25%0.5 |
| Basic earnings per share | -125.71%-0.09 | 78.85%0.93 | 87.01%1.44 | -7.00%2.39 | 34.00%0.67 | -2.78%0.35 | -28.77%0.52 | -11.49%0.77 | -47.12%2.57 | -15.25%0.5 |
| Dividend per share | 0.00%0.185 | 0.00%0.185 | 0.00%0.185 | 1.37%0.74 | 0.00%0.185 | 0.00%0.185 | 0.00%0.185 | 5.71%0.185 | 17.74%0.73 | 5.71%0.185 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.